Mariano Nicolas
Andres Collado
Publications dans lesquelles il/elle collabore avec Mariano Nicolas Andres Collado (12)
2024
2023
-
Association of Gout Polygenic Risk Score With Age at Disease Onset and Tophaceous Disease in European and Polynesian Men With Gout
Arthritis and Rheumatology, Vol. 75, Núm. 5, pp. 816-825
-
The 2023 ACR/EULAR Classification Criteria for Calcium Pyrophosphate Deposition Disease
Arthritis and Rheumatology, Vol. 75, Núm. 10, pp. 1703-1713
-
The 2023 ACR/EULAR classification criteria for calcium pyrophosphate deposition disease
Annals of the Rheumatic Diseases, Vol. 82, Núm. 10, pp. 1248-1257
2022
-
Cutaneous adverse events with febuxostat after previous reactions to allopurinol: comment on the article by Singh and Cleveland
Annals of the Rheumatic Diseases
-
Identifying Potential Classification Criteria for Calcium Pyrophosphate Deposition Disease: Item Generation and Item Reduction
Arthritis Care and Research, Vol. 74, Núm. 10, pp. 1649-1658
2021
-
Correction to: Trans-ancestral dissection of urate- and gout-associated major loci SLC2A9 and ABCG2 reveals primate-specific regulatory effects (Journal of Human Genetics, (2021), 66, 2, (161-169), 10.1038/s10038-020-0821-z)
Journal of Human Genetics
-
Trans-ancestral dissection of urate- and gout-associated major loci SLC2A9 and ABCG2 reveals primate-specific regulatory effects
Journal of Human Genetics, Vol. 66, Núm. 2, pp. 161-169
2020
-
Systematic genetic analysis of early-onset gout: ABCG2 is the only associated locus
Rheumatology (United Kingdom), Vol. 59, Núm. 9, pp. 2544-2549
2019
-
Gout, Hyperuricaemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions of disease states of gout
Annals of the Rheumatic Diseases, Vol. 78, Núm. 11, pp. 1592-1600
-
Gout, Hyperuricemia, and Crystal-Associated Disease Network Consensus Statement Regarding Labels and Definitions for Disease Elements in Gout
Arthritis Care and Research, Vol. 71, Núm. 3, pp. 427-434
2018
-
Improvement in Diagnosis and Treat-to-Target Management of Hyperuricemia in Gout: Results from the GEMA-2 Transversal Study on Practice
Rheumatology and Therapy, Vol. 5, Núm. 1, pp. 243-253